155 related articles for article (PubMed ID: 16312340)
1. In vitro activity of the new quinolones: an overview.
Garcia-Rodriguez JA
J Chemother; 1989 Jul; 1(4 Suppl):136-8. PubMed ID: 16312340
[No Abstract] [Full Text] [Related]
2. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
Cuffini AM; Tullio V; Vaiani G; Carlone NA
J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
[No Abstract] [Full Text] [Related]
3. Preliminary results on the antibacterial and killing activity of lomefloxacin.
Stefani S; Pellegrino MB; Mezzatesta M; Speciale AM; Caccamo F; Russo G; Nicoletti G
J Chemother; 1989 Jul; 1(4 Suppl):170-2. PubMed ID: 16312355
[No Abstract] [Full Text] [Related]
4. Clinical impact of in vitro data with newer quinolones.
Smith JT
J Chemother; 1989 Jul; 1(4 Suppl):662-3. PubMed ID: 16312581
[No Abstract] [Full Text] [Related]
5. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of new 7-piperazinyl-quinolones containing a functionalized 2-(furan-3-yl)ethyl moiety.
Foroumadi A; Mohammadhosseini N; Emami S; Letafat B; Faramarzi MA; Samadi N; Shafiee A
Arch Pharm (Weinheim); 2007 Jan; 340(1):47-52. PubMed ID: 17206610
[TBL] [Abstract][Full Text] [Related]
7. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
Mitscher LA
Chem Rev; 2005 Feb; 105(2):559-92. PubMed ID: 15700957
[No Abstract] [Full Text] [Related]
8. Azthreonam: in vitro activity.
Gobernado M; Cantón E; Santos M
Microbiol Esp; 1983; 36(3-4):123-32. PubMed ID: 6687197
[No Abstract] [Full Text] [Related]
9. [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].
Wang XY; Guo Q; Wang YC; Liu BQ; Liu ML; Sun LY; Guo HY
Yao Xue Xue Bao; 2008 Aug; 43(8):819-27. PubMed ID: 18956774
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
12. Emerging epidemic of metallo-beta-lactamase-mediated resistances.
Jones RN; Biedenbach DJ; Sader HS; Fritsche TR; Toleman MA; Walsh TR
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):77-84. PubMed ID: 15698711
[No Abstract] [Full Text] [Related]
13. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens.
Bonadio M; Maccanti O; Cosci S; Giordani R
J Chemother; 1989 Jul; 1(4 Suppl):58-60. PubMed ID: 16312303
[No Abstract] [Full Text] [Related]
16. [Synthesis and antibacterial activity of dl-7-(4,4-dimethyl-3-aminomethylpyrrolidinyl) -quinolones].
Wang YC; Wang XY; Liu JY; Guo HY
Yao Xue Xue Bao; 2006 Jan; 41(1):58-64. PubMed ID: 16683529
[TBL] [Abstract][Full Text] [Related]
17. In vitro selections of resistant strains by quinolones.
López-Bartolomé O; Avial CR; Picazo JJ; Cabronero MC; Campos E
J Chemother; 1989 Jul; 1(4 Suppl):371-3. PubMed ID: 16312445
[No Abstract] [Full Text] [Related]
18. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
Ko WC; Hsueh PR
J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro activity of new cephem derivatives with benzoxazolone ring.
Mincheva ZP; Kalcheva VB; Golovinsky EG; Tabakova SV
Pharmazie; 1993 Nov; 48(11):859-60. PubMed ID: 8295917
[No Abstract] [Full Text] [Related]
20. [Activity of ciprofloxacin in vitro].
Ferrara A; Donnetta A; Alessandrini R; Grassi FA; Gialdroni Grassi G
G Ital Chemioter; 1986; 33(2-3):99-107. PubMed ID: 3678720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
